Literature DB >> 1881157

How and why should we standardize phytopharmaceutical drugs for clinical validation?

A Bonati1.   

Abstract

Standardized extracts are needed to carry out reliable clinical trials. The standardization of an extract does not include only a whole of analytical controls: it requires also a thorough description of the starting drug and of the whole extraction process, both basic items for the constancy of the quality of an extract. Another not minor aspect in the standardization of an extract is its nomenclature which must include all the necessary data for a clear definition (drug, physical state, solvent of extraction, composition) of the extract itself. Two examples of standardization are described, one concerning an extract whose therapeutical active constituents are known (anthocyanoside complex of Vaccinium myrtillus) and the other concerning an extract whose constituents must be regarded as chemical markers (Pygeum africamum extract).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1881157     DOI: 10.1016/0378-8741(91)90117-v

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  2 in total

Review 1.  Laetrile for cancer: a systematic review of the clinical evidence.

Authors:  Stefania Milazzo; Stephane Lejeune; Edzard Ernst
Journal:  Support Care Cancer       Date:  2006-11-15       Impact factor: 3.359

2.  Formulation and Evaluation of Alstonia boonei Stem Bark Powder Tablets.

Authors:  Salome A Chime; E C Ugwuoke; I V Onyishi; S A Brown; G C Onunkwo
Journal:  Indian J Pharm Sci       Date:  2013-03       Impact factor: 0.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.